Since we demonstrated that HDGF induces ROS generation in hepatoma through surface expression of NCL, it seems plausible that HDGF/NCL signaling might modulate the activity of mitochondrial bioenergetics to promote an increase in ROS in hepatoma cells. The gene discussed is HDGF; the disease is hepatocellular carcinoma.